|
1
|
Shirasaka T: Development history and
concept of an oral anticancer agent S-1(TS-1®): its
clinical usefulness and future vistas. Jpn J Clin Oncol. 39:2–15.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fuwa N: Current and future state of
chemoradiotherapy for head and neck cancer. Nihon Igaku Hoshasen
Gakkai Zasshi. 62:65–72. 2002.(In Japanese).
|
|
3
|
Choong N and Vokes E: Expanding role of
the medical oncologist in the management of head and neck cancer.
CA Cancer J Clin. 58:32–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bernier J, Domenge C, Ozsahlin M, et al:
Postoperative irradiation with or without concomitant chemotherapy
for locally advanced head and neck cancer. N Engl J Med.
350:1945–1952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klug C, Berzaczy D, Voracek M, et al:
Preoperative chemoradiotherapy in the management of oral cancer: A
review. J Craniomaxillofac Surg. 36:75–88. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshizaki T, Tanaka F, Shiga H, et al:
Superselective intra-arterial chemotherapy for head and neck
squamous cell carcinoma. Head and Neck Cancer. 29:445–449. 2003.
View Article : Google Scholar
|
|
7
|
Shiga K, Yokoyama J, Tateda M, et al:
Superselective intraarterial chemotherapy for patients with head
and neck tumor. Head and Neck Cancer. 29:457–462. 2003. View Article : Google Scholar
|
|
8
|
Imai S, Gyoten M, Kajihara Y, et al:
Superselective intraarterial chemotherapy using
cisplatin(CDDP)-carboplatin(CBDCA) combined with radiotherapy for
head and neck cancer. Head and Neck Cancer. 29:463–467. 2003.
View Article : Google Scholar
|
|
9
|
Endo S, Suzuki S, Tsuji K, et al:
Intraarterial concomitant chemoradiation for tongue cancer:
analysis of 20 patients. Nippon Jibiinkoka Gakkai Kaiho.
108:689–693. 2005.(In Japanese).
|
|
10
|
Tohnai I: Intra-arterial chemotherapy for
head and neck cancer. Gan To Kagaku Ryoho. 32:2024–2029. 2005.(In
Japanese).
|
|
11
|
Tonai I, Mitsudo K, Nishiguchi H, et al:
Daily concurrent chemoradiotherapy using superselective
intra-arterial infusion via superficial temporal
artery-preoperative therapy for stage III, IV oral cancer. Head and
Neck Cancer. 31:413–418. 2005.
|
|
12
|
Mitsudo K, Shigetomi T, Fukui T, et al:
Daily concurrent chemoradiotherapy with docetaxel (DOC) and
cisplatin (CDDP) using superselective intra-arterial infusion via
superficial temporal artery for advanced oral cancer. J Clin Oncol.
abse170202009.
|
|
13
|
Harada K, Kawashima Y, Uchida D, et al: A
case of advanced oral squamous cell carcinoma responding to
concurrent radiotherapy. Gan To Kagaku Ryoho. 34:745–747. 2007.(In
Japanese).
|
|
14
|
Tsukuda M, Kida A, Fujii M, et al:
Long-term results of S-1 administration as adjuvant chemotherapy
for advanced head and neck cancer. Gan To Kagaku Ryoho.
34:1215–1225. 2007.(In Japanese).
|
|
15
|
Shirasaki T, Maruya S, Namba A, et al:
Treatment results of chemotherapy with S-1 for head and neck
cancer. Gan To Kagaku Ryoho. 36:237–240. 2009.(In Japanese).
|
|
16
|
Matsui R, Mukai H, Imamura H, et al:
Clinical evaluation of anti-tumor effect in concurrent radiotherapy
with TS-1 for oral cancer (abstract). Jpn J Oral Maxillofac Surg.
55:572009.
|
|
17
|
Ohnishi K, Shioyama Y, Nakamura K, et al:
Concurrent chemoradiotherapy with S-1 as first-line treatment for
patients with oropharyngeal cancer. J Radiat Res. 52:47–53. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Budach W, Hehr T, Budach V, et al: A
meta-analysis of hyperfractionated and accelerated radiotherapy and
combined chemotherapy and radiotherapy regimens in unresectable
locally advanced squamous cell head and neck cancer. BMC Cancer.
6:282006. View Article : Google Scholar
|
|
19
|
Shimosato Y, Oboshi S and Baba K:
Histological evaluation of effects of radiotherapy and chemotherapy
for carcinoma. Jpn J Clin Oncol. 1:19–35. 1971.
|
|
20
|
Böheim K and Spoendkin H: The effect of
chemotherapy in relation to pathohistological tumor grading in head
and neck cancer. Acta Otorhinolaryngol. 238:197–204.
1983.PubMed/NCBI
|
|
21
|
Kishimoto K, Yoshida S, Domaem S, et al:
Concurrent chemoradiotherapy with TS-1 for advanced oral
cancer-Feasibility, problems, and countermeasures for elderly
patients with complication. Jpn J Oral Maxillofac Surg. 55:177–183.
2009.(In Japanese).
|
|
22
|
Zeng L, Ou G, Itasaka S, et al: TS-1
enhances the effect of radiotherapy by suppressing
radiation-induced hypoxia-inducible factor-1 activation and
inducing endothelial cell apoptosis. Cancer Sci. 99:2327–2335.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kirita T, Ohgi K, Kawakami M, et al:
Primary tumor resection of tongue carcinoma based on response to
preoperative therapy. Int J Oral Maxillofac Surg. 31:267–272. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kuratomi Y, Satoh S, Monji M, et al: A
comparative study of concurrent chemoradiotherapy with S-1 or CDDP
for pharyngeal or laryngeal cancer. Gan To Kagaku Ryoho.
37:1471–1476. 2010.(In Japanese).
|
|
25
|
Yamamo N, Ohshima T, Sato T, et al: A case
of interstitial pneumonia after S-1 administration for gastric
cancer. Gan To Kagaku Ryoho. 35:1935–1937. 2008.(In Japanese).
|
|
26
|
Furutani K, Fuwa N, Kodaira T, et al:
Combination therapy of continuous intra-arterial chemotherapy and
radiotherapy for stage III, IV tongue cancer. Head and Neck Cancer.
37:419–423. 2005.
|
